Introduction
============

During the last several decades, many advances in technology have rendered peroral cholangioscopy (POC) a useful diagnostic and therapeutic technique. POC is conducted during endoscopic retrograde cholangiopancreatography (ERCP) in one of three ways: with a dual-operator dedicated ("mother -- daughter") cholangioscopic system, with a single-operator catheter-based cholangioscopic system (SOC), or directly with an ultraslim endoscope or slim gastroscope. The procedures vary with respect to number of operators, maneuverability, image quality, and method of access, resulting in variable success rates.

POC is most commonly used for treating difficult bile duct stones with electrohydraulic lithotripsy or laser lithotripsy or for directly visualizing and/or sampling indeterminate biliary strictures. Other indications and reported uses for POC include, but are not limited to, placing a guidewire during ERCP, monitoring primary sclerosing cholangitis, facilitating stent placement for biliary drainage, assessing the extent of biliary malignancy before surgery, and staging and ablating biliary tumors [@JR350-1] [@JR350-2] [@JR350-3] [@JR350-4]. POC is a safe procedure associated with a low adverse event rate. Variable results have been published in regard to its efficacy and safety for these indications [@OR350-5]. As such, the aim of this study was to perform a systematic review and meta-analysis to assess (i) the overall clinical efficacy of POC for the therapy of difficult bile duct stones, (ii) the accuracy of POC for diagnosing indeterminate biliary strictures, and (iii) the overall adverse event rate of POC.

Patients and methods
====================

This review and meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement [@JR350-6].

Information sources and medical literature search
-------------------------------------------------

A search for eligible publications was conducted via Ovid Medline, the Cochrane Library, and Scopus with the following key words: cholangiopancreatoscopy, choledochoscopy, pancreatocholangioscopy, cholangioscopy, and pancreatoscopy. Two authors (P. K. and S. K.) independently conducted a medical literature search and screened the resulting studies for inclusion. One reviewer (P. K.) extracted data from all studies that met inclusion criteria and stored relevant data in an Excel (Microsoft, Redmond, Washington, USA) database, and a second reviewer (S. K.) performed a second pass of data entry. A third reviewer (S. W.) resolved any discrepancies. EndNote X7 (Thomson Reuters, New York, New York, USA) was used for reference management.

Eligibility criteria
--------------------

For the systematic review, our search included all clinical studies evaluating POC until December 2014.

Inclusion criteria were as follows: (i) studies that investigated POC for the removal of difficult bile duct stones, (ii) studies that investigated POC and its ability to help diagnose indeterminate biliary strictures, (iii) studies that enrolled more than 10 participants, and (iv) full-text articles in English. Notably, difficult bile duct stones were most often defined as stones that could not be removed via conventional methods (ERCP with standard extraction balloons, baskets, or lithotriptors; large endoscopic papillary balloon dilation). Indeterminate biliary strictures were most often defined as strictures that could not be definitively diagnosed with conventional ERCP sampling techniques (brushings, intraductal biopsy).

Exclusion criteria were as follows: (i) case reports, (ii) abstracts, (iii) reviews, (iv) letters to authors or editors, (v) studies evaluating percutaneous cholangioscopy, (vi) animal studies, and (vii) studies evaluating pancreatoscopy only.

Quality assessment
------------------

A modified Newcastle-Ottawa Scale [@OR350-7] was employed to assess the methodological quality of each study included in this review. The studies were divided into two groups: those in which biliary stone removal was an indication for POC and those in which POC was used for the diagnosis of indeterminate strictures; it should be noted that these two groups of studies are not mutually exclusive.

The scale assessed the following for "Selection" criteria: (i) representativeness of the exposed cohort, (ii) ascertainment of exposure, and (iii) demonstration that the outcome of interest was not present at the start of the study. The scale also assessed the following for "Outcome" criteria: (i) assessment by record linkage; (ii) follow-up length, which was determined to be an average follow-up in the study of at least 6 months for both the evaluation of recurrent stones and clinical follow-up for indeterminate strictures; and (iii) percentage of patients lost to follow-up, which was determined to be less than 15 %. Follow-up length and percentage of patients who were lost to follow-up were not used for studies evaluating biliary stone clearance because these factors are not commonly assessed in patients after stone removal.

Thus, according to the modified Newcastle-Ottawa Scale that was used, studies evaluating outcomes of POC for difficult bile duct stones could receive a maximum of four points, and studies evaluating outcomes of POC for indeterminate strictures could receive a maximum of six points. Any question regarding the allocation of points for each study was discussed by three reviewers (P. K., S. K., and S. W.).

List of items and data collected
--------------------------------

The following data elements were extracted (if available) from each study included in the review: (i) publication year; (ii) number of centers involved (single center or multicenter); (iii) setting (university, multicenter, or community); (iv) study design (prospective, retrospective, or randomized controlled trial); (v) type of cholangioscopy (peroral dual-operator dedicated cholangioscope, peroral catheter-based cholangioscope \[SpyGlass; Boston Scientific, Natick, Massachusetts, USA\], direct peroral cholangioscope or ultraslim endoscope); (vi) study focus (stones, strictures, or both); (vii) sample size; (viii) number of POC procedures attempted; (ix) POC technical success rate (i. e., number of successful POC procedures divided by number attempted POC procedures); (x) adverse event rate; (xi) number of patients lost to follow up; and (xii) follow-up period (mean).

For studies evaluating the outcomes of POC for difficult bile duct stones, additional data included the following: (i) number of patients undergoing stone removal (denominator for stone clearance rate); (ii) stone clearance rate (rate of complete stone clearance, not including partial clearance); (iii) average number of stones per patient (mean); (iv) average stone size in millimeters (mean); (v) location of more than 75 % of stones (extrahepatic, intrahepatic, cystic, or mixed); (vi) stone removal technique (cholangioscopy-assisted basket or balloon, electrohydraulic lithotripsy, laser lithotripsy, or multiple methods); and (vii) stone recurrence rate.

For studies in which the outcomes of POC for indeterminate strictures were determined by visual impression only, additional relevant data included the following: (i) number of patients involved in the diagnostic study (denominator for accuracy), (ii) number of patients with true malignant disease (denominator for sensitivity), (iii) number of patients with true benign disease (denominator for specificity), (iv) sensitivity, (v) specificity, (vi) positive predictive value, (vii) negative predictive value, and (viii) accuracy.

For studies in which the outcomes of POC for indeterminate strictures were determined by directed tissue sampling, additional relevant data included the following: (i) number of patients or biopsy samples involved in the diagnostic study (denominator for accuracy), (ii) mean number of biopsy samples per patient/procedure, (iii) number of patients with true malignant disease (denominator for sensitivity), (iv) number of patients with true benign disease (denominator for specificity), (v) sensitivity, (vi) specificity, (vii) positive predictive value, (viii) negative predictive value, and (ix) accuracy.

Outcomes measured
-----------------

The primary outcomes for studies evaluating POC for difficult bile duct stone included the following: (i) technical success rate (ability to achieve selective bile duct access), (ii) stone clearance rate, and (iii) stone recurrence rate. The primary outcomes for studies evaluating POC for indeterminate strictures included the following: (i) technical success rate (ability to achieve selective bile duct access), (ii) accuracy (both visual and directed tissue sampling), (iii) sensitivity (both visual and directed tissue sampling), and (iv) specificity (both visual and directed tissue sampling). The overall adverse event rate related to POC was determined.

Statistical analysis and summary measures
-----------------------------------------

Comprehensive Meta-Analysis Software v2.0 (Biostat, Englewood, New Jersey, USA) was used for all formal meta-analyses (when the number of studies was more than five) to obtain summary estimates of proportions (stone clearance rate, technical success rates, stone recurrence rate, adverse event rates, sensitivities, specificities, and accuracy rates). Because of the assumption of inherently different study scenarios and study populations, a random effects model for all analyses was assumed. Heterogeneity across studies via a chi-squared test on the Q-statistic with appropriate degrees of freedom (dependent on outcome because not all studies uniformly reported all outcomes of interest) and the estimated measure of excess-to-total variation (*I* ^2^) across studies for each outcome of interest were also calculated. In instances in which the degrees of freedom were sufficiently large and there was significant evidence of between-study variation (i. e., heterogeneity), meta-regression to examine potential sources of between-study variation was performed.

Publication bias was assessed via funnel plots and Egger's test on the regression intercept for these plots. In instances of significant evidence of publication bias (*P* \< 0.05), imputed studies were used to create adjusted summary estimates for each measure. Other factors, such as differences in trial quality and true study heterogeneity, could produce asymmetry in funnel plots.

Results
=======

Literature search and included studies
--------------------------------------

The outlined search strategy resulted in the identification of a total of 1028 studies. Based on the defined inclusion and exclusion criteria, a total of 49 studies [@JR350-8] [@JR350-9] [@JR350-10] [@JR350-11] [@JR350-12] [@JR350-13] [@JR350-14] [@JR350-15] [@JR350-16] [@JR350-17] [@JR350-18] [@JR350-19] [@JR350-20] [@JR350-21] [@JR350-22] [@JR350-23] [@JR350-24] [@JR350-25] [@JR350-26] [@JR350-27] [@JR350-28] [@JR350-29] [@JR350-30] [@JR350-31] [@JR350-32] [@JR350-33] [@JR350-34] [@JR350-35] [@JR350-36] [@JR350-37] [@JR350-38] [@JR350-39] [@JR350-40] [@JR350-41] [@JR350-42] [@JR350-43] [@JR350-44] [@JR350-45] [@JR350-46] [@JR350-47] [@JR350-48] [@JR350-49] [@JR350-50] [@JR350-51] [@JR350-52] [@JR350-53] [@JR350-54] [@JR350-55] [@JR350-56] were included in the analysis ([Fig. 1](#FI350-1){ref-type="fig"}). Of the 49 studies evaluated, 33 contained data on difficult bile duct stones ( [Table 1](#TB350-1){ref-type="table"}) and 29 studies contained data on indeterminate strictures ([Table 2](#TB350-2){ref-type="table"}); there were 20 studies focusing only on difficult bile duct stones, 16 studies only on indeterminate strictures, and 13 studies on both.

![ Flow chart of the selection of relevant studies. POC, peroral cholangioscopy.](10-1055-s-0042-100194-i350ei1){#FI350-1}

###### Characteristics of the stone studies included in a systematic review and meta-analysis of the efficacy of peroral cholangioscopy for difficult bile duct stones and indeterminate strictures.

  First author   Year   Setting       Study design    Type of POC           Sample size, n   Technical success rate   Patients undergoing stone removal, n   Stone clearance rate   Stones per patient, mean, n   Stone size, mean, mm   Location of \> 75 % of stones   Stone removal method   Stone recurrence rate   Complication/adverse event rate   Patients lost to follow-up, n   NOS score
  -------------- ------ ------------- --------------- --------------------- ---------------- ------------------------ -------------------------------------- ---------------------- ----------------------------- ---------------------- ------------------------------- ---------------------- ----------------------- --------------------------------- ------------------------------- -----------
  Akerman        2012   Single        Retrospective   Catheter-based         34              0.97                     11                                     0.64                   NR                            NR                     NR                              EHL                    NR                      0                                 NR                              4
  Alameel        2013   Single        Prospective     Catheter-based         30              NR                       10                                     0.9                    NR                            NR                     NR                              EHL                    NR                      0.05                               0                              4
  Arya           2004   Multicenter   Retrospective   Mother -- daughter     94              NR                       94                                     0.9                    1.92                           0                     Mixed                           EHL                    0.04                    0.18                              NR                              4
  Awadallah      2006   Single        Prospective     Mother -- daughter     41              NR                        9                                     0.78                   NR                            NR                     Mixed                           EHL                    NR                      0.05                               1                              4
  Chen           2011   Multicenter   Prospective     Catheter-based        297              0.983                    66                                     0.92                   NR                            NR                     Extrahepatic                    Laser lithotripsy      NR                      0.075                             20                              4
  Chen           2007   Multicenter   Prospective     Catheter-based         35              NR                        9                                     1                      NR                            NR                     NR                              Multiple methods       NR                      0.06                               0                              4
  Draganov       2011   Single        Prospective     Catheter-based         75              0.933                    26                                     0.923                  3.55                          16.52                  NR                              EHL                    NR                      0.048                              0                              4
  Farnik         2014   Multicenter   Retrospective   Ultraslim endoscope    89              0.885                    23                                     NR                     NR                            NR                     NR                              Multiple methods       NR                      0.077                             NR                              3
  Farrell        2005   Single        Prospective     Catheter-based         75              NR                       26                                     1                      NR                            20                     Mixed                           EHL                    NR                      0                                 NR                              4
  Fishman        2009   Single        Retrospective   Catheter-based        128              NR                       41                                     0.87                   NR                            NR                     NR                              EHL                    NR                      0                                 NR                              4
  Huang          2013   Single        Prospective     Ultraslim endoscope    22              0.82                      5                                     1                      NR                            13.4                   NR                              POC-assisted basket    0.182                   0                                  0                              4
  Itoi           2012   Single        Retrospective   Ultraslim endoscope    24              NR                        8                                     1                      NR                            12                     Intrahepatic                    POC-assisted basket    NR                      0                                  0                              4
  Itoi           2010   Single        Retrospective   Mother -- daughter    108              NR                       26                                     1                      2.4                           14.6                   NR                              Multiple methods       NR                      0                                 NR                              4
  Itoi           2014   Multicenter   Prospective     Ultraslim endoscope    41              0.83                      8                                     1                      NR                            NR                     NR                              Multiple methods       NR                      0.048                             NR                              4
  Jakobs         2007   Single        Prospective     Mother -- daughter     89              NR                       17                                     0.824                  NR                            22                     NR                              Laser lithotripsy      NR                      0                                 NR                              3
  Jakobs         1996   Single        Prospective     Mother -- daughter     30              NR                       10                                     0.83                   2.7                           18                     Mixed                           Laser lithotripsy      NR                      NR                                NR                              4
  Kalaitzakis    2012   Multicenter   Retrospective   Catheter-based        165              0.95                     33                                     0.73                   NR                            18                     Extrahepatic                    Multiple methods       NR                      0.09                               4                              4
  Kim            2011   Single        Prospective     Ultraslim endoscope    13              0.923                    13                                     0.923                  2.4                           20.9                   NR                              Laser lithotripsy      NR                      0.077                              0                              4
  Lee TY         2012   Single        Prospective     Ultraslim endoscope    10              NR                       10                                     0.9                    2.3                           19                     Extrahepatic                    Laser lithotripsy      NR                      0.1                                0                              4
  Lee YN         2012   Single        Prospective     Ultraslim endoscope    48              0.958                    13                                     0.846                  2.6                           16.7                   Extrahepatic                    POC-assisted basket    NR                      0                                  0                              4
  Maydeo         2011   Single        Prospective     Catheter-based         64              NR                        60                                    1                      1.5                           23.4                   Extrahepatic                    Laser lithotripsy      NR                      0.133                              0                              4
  Meves          2014   Single        Prospective     Ultraslim endoscope    84              0.87                      11                                    1                      NR                            NR                     NR                              Multiple methods       NR                      0.12                              NR                              4
  Moon           2009   Single        Prospective     Ultraslim endoscope    18              0.944                     18                                    0.89                   2.3                           23.2                   Extrahepatic                    Multiple methods       NR                      0                                  0                              4
  Moon           2009   Single        Prospective     Ultraslim endoscope    29              0.78                       4                                    1                      NR                            NR                     NR                              Multiple methods       NR                      0                                 NR                              4
  Mori           2012   Single        Prospective     Ultraslim endoscope    40              0.925                     13                                    1                      NR                            NR                     NR                              Multiple methods       NR                      0                                 NR                              4
  Neuhaus        1993   Single        Prospective     Mother -- daughter     35              NR                        12                                    0.83                   NR                            20                     Extrahepatic                    Laser lithotripsy      NR                      0                                 NR                              4
  Patel          2014   Multicenter   Prospective     Catheter-based         69              NR                        69                                    0.97                   NR                            NR                     Extrahepatic                    Laser lithotripsy      NR                      0.041                              0                              4
  Piraka         2007   Single        Prospective     Mother -- daughter     32              NR                        32                                    0.81                   NR                            12                     Mixed                           EHL                    0.18                    0.038                              4                              4
  Pohl           2013   Single        RCT             Mixed                  60              0.88                     NR                                     NR                     NR                            NR                     NR                              Multiple methods       NR                      0.117                              0                              3
  Sauer          2013   Single        Retrospective   Mixed                  20              NR                        20                                    0.9                    2.2                           22                     Extrahepatic                    Laser lithotripsy      NR                      0.25                              NR                              4
  Sepe           2012   Single        Retrospective   Catheter-based         13              NR                        13                                    0.769                  NR                             8                     Cystic                          EHL                    0.077                   0                                 NR                              4
  Tsuyuguchi     2011   Single        Prospective     Mother -- daughter    122              NR                       122                                    0.959                  2.9                           17                     NR                              Multiple methods       0.161                   NR                                 6                              3
  Tsuyuguchi     2000   Single        Retrospective   Mother -- daughter     25              0.92                      22                                    0.82                   NR                            20                     NR                              Multiple methods       0.18                    0.16                               1                              4

POC, peroral cholangioscopy; NR, not reported; EHL, electrohydraulic lithotripsy; NOS, Newcastle -- Ottawa Scale.

###### Characteristics of the stricture studies included in a systematic review and meta-analysis of the efficacy of peroral cholangioscopy for difficult bile duct stones and indeterminate strictures.

  First author   Year   Setting       Study design    Type of POC           Sample size   Technical success rate   Patients involved (VISUAL), n   Stricture sensitivity (VISUAL)   Stricture specificity (VISUAL)   Stricture accuracy (VISUAL)   Patients involved (BIOPSY), n   Biopsy samples per patient, mean, n   Stricture sensitivity (BIOPSY)   Stricture specificity (BIOPSY)   Stricture accuracy (BIOPSY)   Complication/adverse event rate   Patients lost to follow-up, n   Duration of follow-up, mean, mo   NOS score
  -------------- ------ ------------- --------------- --------------------- ------------- ------------------------ ------------------------------- -------------------------------- -------------------------------- ----------------------------- ------------------------------- ------------------------------------- -------------------------------- -------------------------------- ----------------------------- --------------------------------- ------------------------------- --------------------------------- -----------
  Akerman        2012   Single        Retrospective   Catheter-based         34           0.97                      0                              NR                               NR                               NR                             0                              NR                                    NR                               NR                               NR                            0                                 NR                               0                                3
  Alameel        2013   Single        Prospective     Catheter-based         30           NR                       19                              0.83                             0.84                             0.84                          16                              NR                                    0.4                              1                                0.81                          0.05                               0                               5                                5
  Albert         2011   Single        Prospective     Ultraslim endoscope    22           0.88                      0                              NR                               NR                               NR                             0                              NR                                    NR                               NR                               NR                            0.045                             NR                               0                                3
  Awadallah      2006   Single        Prospective     Mother -- daughter     41           NR                        0                              NR                               NR                               NR                             0                              NR                                    NR                               NR                               NR                            0.05                               1                               0                                5
  Chen           2011   Multicenter   Prospective     Catheter-based        297           0.983                    95                              0.78                             0.82                             0.8                           95                              3                                     0.49                             0.98                             0.75                          0.075                             20                                \> 6                            6
  Chen           2007   Multicenter   Prospective     Catheter-based         35           NR                       20                              1                                0.77                             0.85                          20                              4.5                                   0.71                             1                                0.9                           0.06                               0                                \> 6                            6
  Draganov       2011   Single        Prospective     Catheter-based         75           0.933                     0                              NR                               NR                               NR                             0                              NR                                    NR                               NR                               NR                            0.048                              0                               0                                3
  Draganov       2012   Single        Prospective     Catheter-based         26           1                         0                              NR                               NR                               NR                            26                              NR                                    0.765                            1                                0.846                         0.077                              0                              21.78                             6
  Farnik         2014   Multicenter   Retrospective   Ultraslim endoscope    89           0.885                     0                              NR                               NR                               NR                             0                              NR                                    NR                               NR                               NR                            0.077                             NR                               0                                3
  Fishman        2009   Single        Retrospective   Catheter-based        128           NR                        0                              NR                               NR                               NR                             0                              NR                                    NR                               NR                               NR                            0                                 NR                               0                                3
  Fukuda         2005   Single        Retrospective   Mother -- daughter     97           1                        76                              1                                0.87                             0.934                          0                              NR                                    NR                               NR                               NR                            0.02                              NR                              \> 12                             6
  Hartman        2012   Single        Retrospective   Catheter-based         89           NR                       15                              0.88                             0.86                             0.87                          29                              3                                     0.57                             1                                0.78                          NR                                 3                              23                                5
  Itoi           2014   Multicenter   Prospective     Ultraslim endoscope    41           0.83                      0                              NR                               NR                               NR                             0                              NR                                    NR                               NR                               NR                            0.048                             NR                               0                                3
  Itoi           2010   Multicenter   Retrospective   Mother -- daughter    144           NR                        0                              NR                               NR                               NR                             0                              1.6                                   NR                               NR                               NR                            0.07                               0                              \> 12                             6
  Kalaitzakis    2012   Multicenter   Retrospective   Catheter-based        165           0.95                      0                              NR                               NR                               NR                            49                              3                                     0.62                             1                                0.84                          0.09                               4                              15                                5
  Khan           2013   Single        Retrospective   NA                     66           NR                        0                              NR                               NR                               NR                            66                              NR                                    0.487                            0.963                            0.68                          NR                                 0                               0                                3
  Liu            2014   Multicenter   Retrospective   Catheter-based         25           NR                        0                              NR                               NR                               NR                             0                              NR                                    NR                               NR                               NR                            0                                 NR                               0                                4
  Manta          2013   Single        Prospective     Catheter-based         52           1                         0                              NR                               NR                               NR                            42                              NR                                    0.88                             0.94                             0.9                           0.038                              0                              24                                6
  Meves          2014   Single        Prospective     Ultraslim endoscope    84           0.87                      0                              NR                               NR                               NR                            26                              NR                                    0.895                            NR                               NR                            0.12                              NR                               0                                4
  Moon           2009   Single        Prospective     Ultraslim endoscope    29           0.78                      0                              NR                               NR                               NR                             0                              NR                                    NR                               NR                               NR                            0                                 NR                               0                                3
  Nguyen         2013   Single        Prospective     Catheter-based         40           0.947                     0                              NR                               NR                               NR                            18                              NR                                    NR                               NR                               0.89                          0.05                              0                               22                                6
  Nishikawa      2013   Single        Prospective     Mother -- daughter     33           1                        33                              1                                0.917                            0.97                          33                              2.39                                  0.381                            1                                0.606                         0.06                              0                               \> 12                             6
  Osanai         2013   Multicenter   Prospective     Mother -- daughter     87           1                        38                              0.964                            0.8                              0.921                         35                              2.4                                   0.815                            1                                0.857                         0.069                             0                               \> 12                             6
  Pohl           2013   Single        RCT             Mixed                  60           0.88                      0                              NR                               NR                               NR                             0                              NR                                    NR                               NR                               NR                            0.117                             0                                 6                               6
  Ramchandani    2011   Single        Prospective     Catheter-based         36           1                        36                              0.95                             0.79                             0.89                          33                              3.5                                   0.82                             0.82                             0.82                          0.083                             0                                 \> 6                            6
  Shah           2006   Single        Prospective     Mother -- daughter     62           NR                        0                              NR                               NR                               NR                             0                              NR                                    NR                               NR                               NR                            0.056                             4                               12.4                              6
  Siddiqui       2012   Single        Retrospective   Catheter-based         30           NR                        0                              NR                               NR                               NR                            30                              NR                                    0.77                             NR                               NR                            0.033                             0                                 \> 6                            6
  Tischendorf    2006   Single        Prospective     Mother -- daughter     53           1                        53                              0.92                             0.93                             0.93                           0                              NR                                    NR                               NR                               NR                            0                                 0                               37                                6
  Woo            2014   Single        Retrospective   Catheter-based         32           NR                       31                              1                                0.9                              0.967                         19                              2.84                                  0.642                            1                                0.736                         0.094                             0                                 \> 6                            6

POC, peroral cholangioscopy; NR, not reported; NA, not applicable; NOS, Newcastle -- Ottawa Scale.

Efficacy of peroral cholangioscopy for difficult bile duct stones
-----------------------------------------------------------------

The overall estimated stone clearance rate (n = 31 studies) was 88 % (95 % confidence interval \[95CI\] 85 % -- 91 %), without significant evidence of heterogeneity (*P* = 0.09, *I* ^2^ = 26.14) ([Fig. 2](#FI350-2){ref-type="fig"}). There was evidence of publication bias (*P* = 0.0466) in this analysis. Imputed values would fall below the estimated mean rate with larger standard errors, and the adjusted stone clearance rate according to the trim and fill method of Duval and Tweedie [@JR350-57] is 85 % (95 %CI 82 % -- 88 %). Study year, study design, stone size, stone location, number of stones, and type of POC had no impact on stone clearance rates based on meta-regression analysis with regard to stone clearance.

![ Forest plot of studies reporting bile duct stone clearance rate with peroral cholangioscopy. Pooled clearance rate was 88 % (95 % confidence interval \[CI\] 85 % -- 91 %).](10-1055-s-0042-100194-i350ei2){#FI350-2}

The estimated stone recurrence rate (n = 6 studies) was 13 % (95 %CI 7 % -- 20 %) ( [Fig. 3](#FI350-3){ref-type="fig"}) with no evidence of heterogeneity (*P* = 0.13, *I* ^2^ = 40.09) or publication bias (*P* = 0.55). The estimated technical success rate (n = 15 studies) was 91 % (95 %CI 88 % -- 94 %) ( [Fig. 4](#FI350-4){ref-type="fig"}), with evidence of heterogeneity (*P* \< 0.01, *I* ^2^ = 61.72). Meta-regression identified a significant association between the type of POC used and technical success rates, with SOC demonstrating higher technical success rates compared with other methods (*P* \< 0.01) ([Fig. 5](#FI350-5){ref-type="fig"}).

![ Forest plot of studies reporting stone recurrence rate after clearance by peroral cholangioscopy. Pooled recurrence rate was 13 % (95 % confidence interval \[CI\] 7 % -- 20 %).](10-1055-s-0042-100194-i350ei3){#FI350-3}

![ Forest plot of studies reporting technical success rate of peroral cholangioscopy for stone-related indications. Pooled success rate was 91 % (95 % confidence interval \[CI\] 88 % -- 94 %).](10-1055-s-0042-100194-i350ei4){#FI350-4}

![ Relationship between technical success rate for stone-related indications and type of peroral cholangioscopy (POC). Single-operator catheter-based cholangiography had a higher rate of technical success for stone-related indications compared with other methods.](10-1055-s-0042-100194-i350ei5){#FI350-5}

Efficacy of peroral cholangioscopy for indeterminate strictures
---------------------------------------------------------------

The diagnostic characteristics of POC for visual impression were as follows ([Table 3](#TB350-3){ref-type="table"}): accuracy (n = 10 studies), 89 % (95 %CI 84 % -- 93 %) ([Fig. 6](#FI350-6){ref-type="fig"}); sensitivity (n = 9 studies), 93 % (95 %CI 85 % -- 97 %); specificity (n = 9 studies), 85 % (95 %CI 79 % -- 89 %). In each case, there was no significant evidence of heterogeneity. The diagnostic characteristics of POC for directed tissue sampling were as follows ([Table 3](#TB350-3){ref-type="table"}): accuracy (n = 13 studies), 79 % (95 %CI 74 % -- 84 %) ( [Fig.7](#FI350-7){ref-type="fig"}); sensitivity (n = 12 studies), 69 % (95 %CI 57 % -- 78 %); specificity (n = 10 studies), 94 % (95 %CI 89 % -- 97 %). Meta-regression identified a significant association between the type of POC used and visual accuracy (*P* \< 0.01) and between the type of POC used and visual sensitivity (*P* = 0.01), with dual-operator cholangioscopy having higher rates compared with SOC. There was a potential trend toward an association between the number of biopsies and accuracy (*P* = 0.077) such that an increased number of biopsies was associated with increased accuracy. The estimated technical success rate (n = 18 studies) was 94 % (95 %CI 90 % -- 96 %) ([Fig. 8](#FI350-8){ref-type="fig"}), with significant evidence of heterogeneity (*P* \< 0.011, *I* ^2^ = 67.39).

###### Efficacy and safety of peroral cholangioscopy for the removal of bile duct stones and the diagnosis of indeterminate strictures.

  --------------------------------------------------------------------------------------------------------------------
                            **Estimated**   **95 % CI**    ***I*^2^**   **Heterogeneity?**\   **Publication bias?**\
                                                                        **(*P* value)**       **(*P* value)**
  ------------------------- --------------- -------------- ------------ --------------------- ------------------------
  Stones                                                                                      

   Clearance rate           88 %            85 % -- 91 %   26.14        No (0.09)             Yes (0.05)

   Recurrence rate          13 %             7 % -- 20 %   40.09        No (0.14)             No (0.56)

   Technical success rate   91 %            88 % -- 94 %   61.72        Yes ( \< 0.01)        No (0.32)

  Strictures                                                                                  

   Visual accuracy          89 %            84 % -- 93 %   35.21        No (0.13)             Yes (0.01)

   Visual sensitivity       93 %            85 % -- 97 %   38.46        No (0.11)             Yes ( \< 0.01)

   Visual specificity       85 %            79 % -- 89 %    0           No (0.84)             No (0.50)

   Biopsy accuracy          79 %            74 % -- 84 %   19.12        No (0.09)             Yes (0.01)

   Biopsy sensitivity       69 %            57 % -- 78 %   97.97        Yes ( \< 0.01)        No (0.07)

   Biopsy specificity       94 %            89 % -- 97 %    0           No (0.88)             No (0.18)

   Technical success rate   94 %            90 % -- 96 %   67.39        Yes ( \< 0.01)        Yes ( \< 0.01)

  Adverse event rate                                                                          

   Overall                   7 %             6 % -- 9 %    32.36        Yes (0.02)            Yes ( \< 0.01)

   Pancreatitis              2 %             2 % -- 3 %     0           No (0.99)             Yes ( \< 0.01)

   Cholangitis               4 %             3 % -- 5 %    25.55        No (0.06)             Yes ( \< 0.01)

   Perforation               1 %             1 % -- 2 %     0           No (0.99)             No (0.73)

   Other events              3 %             2 % -- 4 %    37.74        Yes (0.01)            Yes ( \< 0.01)

   Serious events            1 %             1 % -- 2 %     0           No (0.99)             No (0.28)
  --------------------------------------------------------------------------------------------------------------------

CI, confidence interval.

![ Forest plot of studies reporting visual accuracy of peroral cholangioscopy in diagnosing indeterminate biliary strictures. Pooled accuracy rate was 89 % (95 % confidence interval \[CI\] 84 % -- 93 %).](10-1055-s-0042-100194-i350ei6){#FI350-6}

![ Forest plot of studies reporting biopsy accuracy of peroral cholangioscopy in diagnosing indeterminate biliary strictures. Pooled accuracy rate was 79 % (95 % confidence interval \[CI\] 74 % -- 94 %).](10-1055-s-0042-100194-i350ei7){#FI350-7}

![ Forest plot of studies reporting technical success rate of peroral cholangioscopy for stricture-related indications. Pooled success rate was 94 % (95 % confidence interval \[CI\] 90 % -- 96 %).](10-1055-s-0042-100194-i350ei8){#FI350-8}

Adverse events of peroral cholangioscopy
----------------------------------------

The estimated overall adverse event rate was 7 % (95 %CI 6 % -- 9 %) ( [Fig.9](#FI350-9){ref-type="fig"}). The estimated rates of pancreatitis, cholangitis, perforation, and other adverse events were 2 % (95 %CI 2 % -- 3 %), 4 % (95 %CI 3 % -- 5 %), 1 % (95 %CI 1 % -- 2 %), and 3 % (95 %CI 2 % -- 4 %), respectively. The estimated rate of severe adverse events was 1 % (95 %CI 1 % -- 2 %).

![ Forest plot of studies reporting overall adverse event rates of peroral cholangioscopy. Pooled event rate was 7 % (95 % confidence interval \[CI\] 6 % -- 9 %).](10-1055-s-0042-100194-i350ei9){#FI350-9}

Discussion
==========

POC has become a valuable tool for the treatment of difficult bile duct stones and the evaluation of indeterminate strictures. Despite increasing clinical use, there are very limited composite data evaluating its efficacy and safety. The aims of this study were to systematically review and analyze the efficacy of POC for difficult bile duct stones and indeterminate biliary strictures. The results of this systematic review and meta-analysis demonstrate a high stone clearance rate with the use of POC for difficult bile duct stones (88 %, 95 %CI 85 % -- 91 %). Similarly, POC showed an accuracy of 89 % (95 %CI 84 % -- 93 %) for visual impression of indeterminate biliary strictures and of 79 % (95 %CI 74 % -- 84 %) for directed tissue sampling. Finally, POC was noted to have an overall low adverse event rate (7 %, 95 %CI 6 % -- 9 %).

This analysis found that the accuracy of the visual impression was greater than biopsy-related accuracy, likely because of the high sensitivity of visual impression and poor sensitivity of biopsies. Currently, there is no standardized classification system used to help make a visual diagnosis of malignancy. However, studies evaluating POC for visual impression used characteristics such as the presence of irregular mucosa, an intraductal mass, or a tumor vessel to qualify a lesion as malignant, as these findings are often suggestive of malignancy [@JR350-9] [@JR350-14] [@JR350-20] [@JR350-43] [@JR350-44] [@JR350-48] [@JR350-53] [@JR350-56]. It should be noted, however, that the data on the diagnostic characteristics of these individual characteristics are limited at the present time. Given the low specificity of visual impression, it cannot be used alone to confirm a diagnosis. This analysis also found that SOC systems had a significantly reduced sensitivity for visual impression when compared with dual-operator cholangioscopes. This is likely due to the fact that SOC systems provide a fiberoptic image that is of poorer quality than the digital image obtained with dual-operator cholangioscopes.

The suboptimal biopsy-related accuracy of POC was attributed to low overall sensitivity. This highlights the technical challenges of sampling indeterminate biliary strictures and calls for an improvement in tissue acquisition techniques. Our analysis found a statistically insignificant but potential trend toward greater accuracy with an increased number of biopsies. As suggested by Kalaitzakis et al. [@JR350-29], taking more biopsy samples may result in an increased sensitivity (and potentially accuracy) for making a histological diagnosis. The high sensitivity of visual impression and high specificity of POC-directed biopsy make a combined approach, rather than the individual use of each, likely the most helpful method for making a diagnosis of malignancy.

Two meta-analyses [@JR350-58] [@JR350-59] have assessed the efficacy and diagnostic performance of SOC for indeterminate biliary strictures. One study [@JR350-58] concluded that visual impression is useful for detecting a malignant lesion, and the other [@JR350-59] that SOC biopsies have a moderate sensitivity for diagnosing malignant strictures. Both studies revealed that SOC is useful in confirming a malignant diagnosis because of its high specificity. One notable difference in this meta-analysis is that the studies involved looked at all types of POC and were not limited to SOC. However, the data from this meta-analysis are in concordance with those of the aforementioned meta-analyses in that they reveal a high sensitivity of visual impression for the detection of malignant strictures and a high specificity associated with biopsy that can be useful in the confirmation of a malignant diagnosis.

POC appears to be a relatively safe procedure with a very low rate of serious events (1 %, 95 %CI 1 % -- 2 %). The data obtained in this systematic review and meta-analysis provide point estimates of adverse events that may be used in discussions with patients before a procedure. Notably, the patients undergoing POC have failed ERCP; this may be because they have more difficult anatomy or unusual lesions that require more manipulation. As such, there is a component of selection bias when patients are chosen to undergo POC. A recent study [@JR350-60], completed in Sweden based on a national registry, reported that the risk for intra- and post-procedural adverse events is significantly increased when a patient undergoes POC in conjunction with ERCP, as opposed to ERCP alone. However, the study also noted that in a multivariate analysis that adjusted for confounders, the risk for pancreatitis and cholangitis was not increased. Of note, a systematic survey evaluating the incidence rates of post-ERCP complications [@JR350-61] revealed an ERCP complication rate of approximately 6.85 %, with a severe event rate of approximately 1.67 %. These figures are comparable with the adverse event rates for POC estimated in this meta-analysis. Overall, it is clear that further research and data comparing POC with ERCP alone or with EUS are needed to compare the rates of adverse events and determine whether there is an increased adverse event rate with POC.

Limitations to this analysis included study heterogeneity and variability in the type of POC used. The studies had various patient populations, and the procedures were completed by using various methods of POC as well as differing instruments within each method. Furthermore, interoperator variability cannot be accounted for. Also, the definition of adverse event varied from study to study and accounted only for what was reported by the authors of each study. For example, some studies documented minor bleeding and considered it an adverse event, whereas others did not. It should also be noted that are various types of difficult stones -- large stones, confluence stones, impacted stones, etc. Although the meta-regression found no association between the size and location of stones, confluence stones and impacted stones were not specifically addressed in most studies. Therefore, they could not be distinctly evaluated in this analysis. Finally, it is important to make a distinction between filling defects caused by malignant strictures and filling defects caused by extrinsic compression/factors. Unfortunately, information on the latter was often very limited and not made distinct in the literature. Thus, the use of POC for detecting malignancy in filling defects caused by external compression or other factors could not be analyzed in this study.

POC is a safe and effective adjunctive tool with ERCP for the evaluation of bile duct strictures and for the treatment of bile duct stones when conventional methods have failed. Despite the increasing utilization of POC and technical advances such as the recently introduced digital single-operator cholangioscope, the current systematic review and meta-analysis confirm the paucity of high level evidence supporting the use of POC. Prospective, controlled clinical trials are needed to further elucidate the precise role of POC and develop criteria that can be used to standardize the diagnosis and treatment of pancreaticobiliary diseases.
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